(Q40088228)

17 September 2017

1 reference

title

Ventricular antiarrhythmic effects of beta-adrenergic blocking drugs: a review of mechanism and clinical studies (English)

1 reference

17 September 2017

Pratt C

1

1 reference

17 September 2017

Lichstein E

series ordinal

2

1 reference

17 September 2017

publication date

1 August 1982

1 reference

The Journal of Clinical Pharmacology

17 September 2017

published in

1 reference

17 September 2017

volume

22

1 reference

17 September 2017

issue

8-9

1 reference

17 September 2017

page(s)

335-347

1 reference

The use of beta-adrenergic receptor blocking drugs in dysrhythmias

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Appraisal of the effects of catecholamines on cardiac electrical activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Cardiovascular injury induced by sympathetic catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Clinical evaluation of practolol in acute arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Effect of Sotalol on clinical arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Pharmacologic therapy of ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Perspectives in adrenergic beta-receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Neural Activity and Ventricular Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Ventricular electrical instability in the conscious dog: effects of psychologic stress and beta adrenergic blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Psychological stress and ventricular arrhythmias during myocardial infarction in the conscious dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Modification of ventricular fibrillation latency following coronary artery occlusion in the conscious pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Emotional Stress and Cardiac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Roles of psychologic stress and autonomic nervous system changes in provocation of ventricular premature complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Letter: Role of catecholamines in arrhythmias after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Characterization and localization of ventricular arrhythmias resulting from myocardial ischemia and infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Identification of sudden death risk factors in acute and chronic coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Ventricular Premature Beats and Mortality after Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Ventricular premature beats and anatomically defined coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Ventricular Arrhythmia in Chronic Stable Angina Pectoris with Surgical or Medical Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Propranolol and lidocaine. Clinical use as antiarrhythmic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Treatment of arrhythmias with pindolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Propranolol in the treatment of digitalis-induced and digitalis-resistant tachycardias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

??-Adrenoceptor Blocking Drugs and Acute Myocardial Infarction1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Use of Oxprenolol in Cardiac Arrhythmias Associated with Acute Myocardial Ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

The effects of practolol on the dysrhythmias complicating acute ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Idiopathic paroxysmal ventricular tachycardia in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Present state of alpha and beta adrenergic drugs III. Beta blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Basis for Recurring Ventricular Fibrillation in the Absence of Coronary Heart Disease and Its Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

Control of persistent ventricular ectopic beats by alprenolol, a new beta-adrenergic blocking agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02684.X

10.1002/J.1552-4604.1982.TB02684.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference